- Home
- INBX vs PMT Comparison
INBX vs PMT Comparison
Compare INBX & PMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INBX | PMT |
|---|---|---|
| Founded | 2010 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2020 | 2009 |
Fundamental Metrics
Financial Performance| Metric | INBX | PMT |
|---|---|---|
| Price | $76.49 | $12.66 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 4 |
| Target Price | N/A | ★ $13.67 |
| AVG Volume (30 Days) | 201.6K | ★ 1.5M |
| Earning Date | 03-16-2026 | 01-29-2026 |
| Dividend Yield | N/A | ★ 12.66% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.99 |
| Revenue | $1,400,000.00 | ★ $721,170,000.00 |
| Revenue This Year | $563.00 | N/A |
| Revenue Next Year | N/A | $8.09 |
| P/E Ratio | ★ N/A | $12.78 |
| Revenue Growth | N/A | ★ 42.92 |
| 52 Week Low | $10.81 | $11.60 |
| 52 Week High | $94.57 | $14.93 |
Technical Indicators
Market Signals| Indicator | INBX | PMT |
|---|---|---|
| Relative Strength Index (RSI) | 56.01 | 44.10 |
| Support Level | $77.24 | $11.88 |
| Resistance Level | $88.72 | $12.65 |
| Average True Range (ATR) | 4.93 | 0.38 |
| MACD | 0.54 | -0.04 |
| Stochastic Oscillator | 68.86 | 34.28 |
Price Performance
Historical ComparisonAbout INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
About PMT PennyMac Mortgage Investment Trust of Beneficial Interest
PennyMac Mortgage Investment Trust is a specialty finance company that invests primarily in residential mortgage loans and mortgage-related assets. The company's operations include activities such as the production and servicing of financial securities based on residential loans and the pooling and reselling of high-credit-quality mortgages. The company operates through three segments: correspondent production, credit-sensitive strategies, interest-rate-sensitive strategies. The Credit sensitive strategies segment generates income via investments in CRT arrangements, subordinate MBS, distressed loans, and real estate.